Alkermes PLC.

ALKS Nasdaq Healthcare · Pharmaceutical Preparations Dublin 4, Ireland www.alkermes.com/
$41.65
Mkt Cap 6.99B

Biopharmaceutical company developing and marketing neuroscience medicines, including treatments for schizophrenia, bipolar disorder, and alcohol and opioid dependence.

alkermes.com ↗Summary by The Compound Family, based on the company’s own website
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$1.67B
7.3% CAGR
FCF TTM
$221.7M
13.3% margin
P/E RATIO
105.7x
—
P/FCF
31.5x
—
Running full 6-factor analysis…